Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GALCANEZUMAB-GNLM Cause Post procedural complication? 15 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Post procedural complication have been filed in association with GALCANEZUMAB-GNLM. This represents 0.1% of all adverse event reports for GALCANEZUMAB-GNLM.

15
Reports of Post procedural complication with GALCANEZUMAB-GNLM
0.1%
of all GALCANEZUMAB-GNLM reports
0
Deaths
3
Hospitalizations

How Dangerous Is Post procedural complication From GALCANEZUMAB-GNLM?

Of the 15 reports, 3 (20.0%) required hospitalization.

Is Post procedural complication Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GALCANEZUMAB-GNLM. However, 15 reports have been filed with the FAERS database.

What Other Side Effects Does GALCANEZUMAB-GNLM Cause?

Injection site pain (6,622) Underdose (2,909) Migraine (2,612) Headache (2,104) Drug ineffective (1,610) Product dose omission issue (1,591) Injection site haemorrhage (1,415) Accidental underdose (1,064) Injection site erythema (1,052) Injection site pruritus (774)

What Other Drugs Cause Post procedural complication?

ADALIMUMAB (2,494) ETANERCEPT (318) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (244) UPADACITINIB (241) RISANKIZUMAB-RZAA (232) INFLIXIMAB (217) METHOTREXATE (188) TREPROSTINIL (174) HUMAN IMMUNOGLOBULIN G (159) PREDNISONE (157)

Which GALCANEZUMAB-GNLM Alternatives Have Lower Post procedural complication Risk?

GALCANEZUMAB-GNLM vs GALLIUM GA-OZETOTIDE GALCANEZUMAB-GNLM vs GALSULFASE GALCANEZUMAB-GNLM vs GAMMAGARD LIQUID GALCANEZUMAB-GNLM vs GANAXOLONE GALCANEZUMAB-GNLM vs GANCICLOVIR

Related Pages

GALCANEZUMAB-GNLM Full Profile All Post procedural complication Reports All Drugs Causing Post procedural complication GALCANEZUMAB-GNLM Demographics